Brief: Jounce Therapeutics To Be Acquired By Concentra Biosciences

Redx Pharma

27/03/2023 14:09

March 27 (Reuters) - Jounce Therapeutics Inc  JNCE.O :
    * JOUNCE THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED
BY
CONCENTRA BIOSCIENCES FOR $1.85 IN CASH PER SHARE PLUS
CONTINGENT VALUE RIGHTS
    * JOUNCE THERAPEUTICS ENTERS INTO AGREEMENT TO BE ACQUIRED
BY
CONCENTRA BIOSCIENCES FOR $1.85 IN CASH PER SHARE PLUS
CONTINGENT VALUE RIGHTS
    * JOUNCE THERAPEUTICS - BOARD OF DIRECTORS IS NO LONGER
RECOMMENDING PROPOSED ALL-SHARE MERGER TRANSACTION WITH REDX
PHARMA PLC
    * JOUNCE THERAPEUTICS INC - IMPLEMENTING A WORKFORCE
REDUCTION OF
APPROXIMATELY 84% OF ITS EMPLOYEES
    * JOUNCE THERAPEUTICS INC - REDUCTION IS EXPECTED TO BE
COMPLETED
WITHIN NEXT MONTH AND JOUNCE WILL INCUR RESTRUCTURING COSTS
TOTALING ABOUT $6.5 MILLION

Source text for Eikon:  ID:nGNXgRkKy 
Further company coverage:  JNCE.O 

 ((Reuters.Briefs@thomsonreuters.com;))